Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.

He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, Lin SH.

BMC Cancer. 2015;15:1095. doi: 10.1186/s12885-015-1095-2. Epub 2015 Mar 9.

2.

Synthesis, characterization and DFT studies of two new pi-conjugated-conjugated pyridine-based tetrathiafulvalene derivatives.

Niu ZG, He LR, Li L, Cheng WF, Li XA, Chen HH, Li GN.

Acta Chim Slov. 2014;61(4):786-91.

PMID:
25551718
3.

Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.

Zhang P, Xi M, Zhao L, Li QQ, He LR, Liu SL, Shen JX, Liu MZ.

Radiat Oncol. 2014 Nov 26;9:256. doi: 10.1186/s13014-014-0256-9.

4.

The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy.

Zhang P, Xi M, Li QQ, He LR, Liu SL, Zhao L, Shen JX, Liu MZ.

J Cancer. 2014 Sep 6;5(8):689-95. doi: 10.7150/jca.9569. eCollection 2014.

5.

Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?

Zhang P, Xi M, Zhao L, Shen JX, Li QQ, He LR, Liu SL, Liu MZ.

PLoS One. 2014 Aug 18;9(8):e105270. doi: 10.1371/journal.pone.0105270. eCollection 2014.

6.

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Tian XP, Qian D, He LR, Huang H, Mai SJ, Li CP, Huang XX, Cai MY, Liao YJ, Kung HF, Zeng YX, Xie D.

Cancer Lett. 2014 Oct 10;353(1):104-14. doi: 10.1016/j.canlet.2014.07.012. Epub 2014 Jul 18.

PMID:
25045845
7.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Liu JY, Qian D, He LR, Li YH, Liao YJ, Mai SJ, Tian XP, Liu YH, Zhang JX, Kung HF, Zeng YX, Zhou FJ, Xie D.

Mol Cancer. 2013 Nov 23;12(1):148. doi: 10.1186/1476-4598-12-148.

8.

Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.

Chen YF, Ma G, Cao X, Luo RZ, He LR, He JH, Huang ZL, Zeng MS, Wen ZS.

BMC Surg. 2013 May 28;13:15. doi: 10.1186/1471-2482-13-15.

9.

β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.

Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang J, Ping YF, Wang B, Yang L, Xu SL, Cui W, Wang QL, Fu WJ, Liu Q, Qian C, Cui YH, Rich JN, Kung HF, Zhang X, Bian XW.

Cancer Res. 2013 May 15;73(10):3181-9. doi: 10.1158/0008-5472.CAN-12-4403. Epub 2013 Mar 28.

10.

The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.

Qian D, Zhang B, He LR, Cai MY, Mai SJ, Liao YJ, Liu YH, Lin MC, Bian XW, Zeng YX, Huang JJ, Kung HF, Xie D.

J Pathol. 2013 Apr;229(5):765-74. doi: 10.1002/path.4163. Epub 2013 Feb 22.

PMID:
23341363
11.

[Ear reconstruction after rupture of postauricular expanded flap].

Hu SD, He LR, Zhao YY, Jiang HY, Yang QH, Zhuang HX.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2012 Sep;28(5):328-31. Chinese.

PMID:
23259303
12.

Using the theory of coevolution to predict protein-protein interactions in non-small cell lung cancer.

Zhang M, Chan MH, Tu WJ, He LR, Lee CM, He M.

Chin J Cancer. 2013 Feb;32(2):91-8. doi: 10.5732/cjc.012.10100. Epub 2012 Dec 14.

13.

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.

Zhao L, He LR, Xi M, Cai MY, Shen JX, Li QQ, Liao YJ, Qian D, Feng ZZ, Zeng YX, Xie D, Liu MZ.

J Transl Med. 2012 Dec 11;10:249. doi: 10.1186/1479-5876-10-249.

14.

Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history.

Yu W, He LR, Zhao YC, Chan MH, Zhang M, He M.

Chin J Cancer. 2013 Feb;32(2):84-90. doi: 10.5732/cjc.012.10099. Epub 2012 Nov 13.

15.
16.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
17.

The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.

Zhao L, Li QQ, Zhang R, Xi M, Liao YJ, Qian D, He LR, Zeng YX, Xie D, Liu MZ.

Tumour Biol. 2012 Aug;33(4):1115-23. doi: 10.1007/s13277-012-0352-0. Epub 2012 Mar 3.

PMID:
22389159
18.

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D, Xi M, Zeng YX, Xie D, Liu MZ.

Med Oncol. 2012 Dec;29(4):2669-76. doi: 10.1007/s12032-011-0133-4. Epub 2011 Dec 14.

PMID:
22167391
19.

[Clinical advances in non-invasive ventilation and cardiogenic acute pulmonary edema].

He LR, Kuang JL.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Sep;23(9):574-6. Review. Chinese. No abstract available.

20.

Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.

Cao X, Luo RZ, He LR, Li Y, Lin WQ, Chen YF, Wen ZS.

Radiat Oncol. 2011 Aug 26;6:104. doi: 10.1186/1748-717X-6-104.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk